Prevention of Chemotherapy-Induced Cardiotoxicity in High-Risk Patients
|2||Active, not recruiting||
Clinical Trial to Evaluate R-COMP Versus R-CHOP in Newly Diagnosed Patients With Non-localised Diffuse Large B-cell Lymphoma (DLBCL)/Follicular Lymphoma Grade IIIb
Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients
† Study has passed its completion date and status has not been verified in more than two years.